Pancreatic
Showing 26 - 50 of 8,167
Pancreatic Cancer Trial in Shanghai (Adebrelimab, mRNA tumor vaccines)
Not yet recruiting
- Pancreatic Cancer
- Adebrelimab
- mRNA tumor vaccines
-
Shanghai, Shanghai, ChinaDepartment of Pancreatic Surgery, Fudan University Shanghai Canc
Dec 4, 2023
Hepatocarcinoma, Pancreatic Tumor Trial in Clichy (Hepatocellular carcinoma, Pancreatic adenocarcinoma, Pancreatic
Recruiting
- Hepatocarcinoma
- Pancreatic Tumor
- Hepatocellular carcinoma
- +2 more
-
Clichy, FranceHôpital Beaujon
Mar 20, 2023
Metastatic Pancreatic Cancer, Terminal Cancer Trial in Shanghai (Ascorbate)
Recruiting
- Metastatic Pancreatic Cancer
- Terminal Cancer
-
Shanghai, Shanghai, ChinaShanghai Cancer Center
Aug 29, 2023
EHR-based Pancreatic Cancer Risk Model
Active, not recruiting
- Pancreatic Adenocarcinoma
- Predictive Cancer Model
- Pancreatic Cancer Risk Model (PRISM)
-
Boston, MassachusettsBeth Israel Deaconess Medical Center
Aug 1, 2023
Periampullary Cancer, Postoperative Pancreatic Fistula Trial in Dresden (Intraportal transplantation of isolated autologous
Not yet recruiting
- Periampullary Cancer
- Postoperative Pancreatic Fistula
- Intraportal transplantation of isolated autologous pancreatic islets after total pancreatectomy
- Pancreaticoduodenectomy (classic Whipple or pylorus-preserving)
-
Dresden, GermanyUniversity Hospital Carl Gustav Carus Technische Universität Dre
Apr 24, 2023
Quality of Life in Elderly Patients After Pancreatic Cancer
Recruiting
- Pancreatic Cancer
- +2 more
- Phone call
-
Lyon, FranceService de Gériatrie aigue, Hôpital Edouard Herriot, Hospices Ci
Oct 6, 2023
Pancreatic Adenocarcinoma, Homologous Recombination Deficiency Trial (Cisplatin)
Not yet recruiting
- Pancreatic Adenocarcinoma
- Homologous Recombination Deficiency
- (no location specified)
Oct 18, 2023
Palliative Therapy for Pancreatic Cancer Patient
Recruiting
- Pancreatic Cancer
- Observational study
-
Beijing, Beijing, ChinaPeking Union Medical College Hospital
Oct 17, 2023
Pancreatic Cancer, Periampullary Cancer, Frailty Syndrome Trial in Milan (Multimodal Prehabilitation)
Recruiting
- Pancreatic Cancer
- +4 more
- Multimodal Prehabilitation
-
Milan, Lombardia, ItalySan Raffaele Hospital
Sep 29, 2023
Tumor Exosome Liquid Biopsy Strategy to Diagnose Pancreatic
Enrolling by invitation
- Pancreatic
-
Shanghai, Shanghai, ChinaXinhua Hospital, Affiliated to Shanghai Jiao Tong University, Sc
Oct 25, 2023
Pancreatic Cancer Trial in Dublin (Control, Intervention)
Not yet recruiting
- Pancreatic Cancer
- Control
- Intervention
-
Dublin, Leinster, IrelandSt Vincent's University Hospital
Nov 20, 2023
Serum Lipase and Severity of Pancreatic Injury.
Completed
- Pancreatic Injury
- data collection
-
Saint-Étienne, FranceCHU Saint-Etienne
Aug 3, 2023
Stage III Pancreatic Cancer American Joint Committee on Cancer (AJCC) v8, Stage IV Pancreatic Cancer AJCC v8, Unresectable
Recruiting
- Stage III Pancreatic Cancer American Joint Committee on Cancer (AJCC) v8
- +2 more
- Best Practice
- +5 more
-
Los Angeles, CaliforniaUCLA / Jonsson Comprehensive Cancer Center
Oct 13, 2023
Pancreatic Cancer, Chronic Pancreatitis Trial in Amsterdam (Lidocaine IV)
Recruiting
- Pancreatic Cancer
- Chronic Pancreatitis
- Lidocaine IV
-
Amsterdam, Noord-Holland, NetherlandsAmsterdam UMC, locatie AMC
Jun 14, 2023
Locally Advanced Pancreatic Cancer Trial (Stereotactic body radiation(SBRT), Zimberelimab (GLS-010))
Not yet recruiting
- Locally Advanced Pancreatic Cancer
- Stereotactic body radiation(SBRT)
- Zimberelimab (GLS-010)
- (no location specified)
Aug 22, 2023
Pancreatic Cancer Trial in ShangHai (TCR-T Cells Injection(GB3010 Cells Injection))
Recruiting
- Pancreatic Cancer
- TCR-T Cells Injection(GB3010 Cells Injection)
-
ShangHai, Shanghai, ChinaRuijin Hospital Affiliated to Shanghai Jiaotong University Schoo
Sep 19, 2023
Pancreatic Cancer Metastatic Trial (C3 (Metformin, Simvastatin, and Digoxin))
Not yet recruiting
- Pancreatic Cancer Metastatic
- C3 (Metformin, Simvastatin, and Digoxin)
- (no location specified)
Sep 1, 2023
Pancreatic Adenocarcinoma Trial (mFOLFIRINOX plus radiotherapy)
Not yet recruiting
- Pancreatic Adenocarcinoma
- mFOLFIRINOX plus radiotherapy
- (no location specified)
Nov 21, 2023
Pancreatic Cancer Trial in Hangzhou (Canagliflozin and Gemcitabine, Gemcitabine)
Not yet recruiting
- Pancreatic Cancer
- Canagliflozin and Gemcitabine
- Gemcitabine
-
Hangzhou, Zhejiang, ChinaHangzhou first people's Hospital
Jun 11, 2023
Group of Pancreatic Surgery Definition and Grading Criteria for
Active, not recruiting
- Laparoscopic Pancreatic Surgery
- +3 more
- (no location specified)
Dec 10, 2022
Extracorporeal Shock Wave Lithotripsy for Pancreatic Stones
Recruiting
- Pancreatic Duct Stone
- pancreatic extracorporeal shock wave lithotripsy
-
Shanghai, ChinaChanghai Hospital
Jun 27, 2023
Pancreatic Carcinoma Trial in Shanghai (carbon ion radiotherapy)
Recruiting
- Pancreatic Carcinoma
- carbon ion radiotherapy
-
Shanghai, Shanghai, ChinaShanghai Proton and Heavy Ion Center
Apr 25, 2023
HER-2 Expression in Pancreatic Duct Adenocarcinoma
Completed
- Pancreatic Adenocarcinoma
- immunohistochemical approach
- (no location specified)
Sep 20, 2023
Pancreatic Cancer Trial in Nanjing (Trilaciclib+mFOLFIRINOX)
Not yet recruiting
- Pancreatic Cancer
-
Nanjing, Jiangsu, ChinaThe Affiliated Hospital of Nanjing University Medical School
Nov 21, 2023